Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Penicillin-binding proteins are a family of enzymes central to the synthesis and remodeling of bacterial cell walls. They catalyze the transpeptidation reaction that cross-links peptidoglycan polymers, conferring mechanical strength and shape to bacteria. These proteins are the molecular targets of β-lactam antibiotics (such as penicillins and cephalosporins), which covalently bind to their active site serine, inhibiting their enzymatic activity and thus preventing cell wall formation. PBP1 is often a bifunctional enzyme with transglycosylase and transpeptidase domains, while PBP3 is primarily a transpeptidase, both crucial for cell division and morphogenesis. Alterations in PBPs are a common mechanism of antibiotic resistance in clinically important bacteria.
Covalent binding of β-lactam ring of antibiotics to the active site serine of PBPs results in enzyme inactivation and blockade of peptidoglycan cross-linking, leading to cell death. Inhibition of transpeptidase activity halts cell wall synthesis, weakening the bacterium and causing lysis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Penicillin-binding protein 1; Penicillin-binding protein 3 (PBP1; PBP3).